Bimatoprost
Side effects
Options:
Show MedDRA Preferred Terms
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
Pruritus
|
very common
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Growth of eyelashes
|
very common, 5% - 53.6%
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Conjunctival hyperaemia
|
very common, 3.4% - 56.1%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Eye pruritus
|
3.3% - 17.6%
|
|
x
|
x
|
|
|
|
|
|
|
x
|
x
|
Dry eye
|
2.1% - 11.6%
|
|
x
|
x
|
|
|
|
|
|
|
|
x
|
Burning sensation in eye
|
6.6% - 10.4%
|
|
|
|
|
|
|
|
|
|
|
x
|
Blepharal pigmentation
|
0.4% - 11.4%
|
|
|
|
|
|
|
|
|
|
|
x
|
Headache
|
common
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Photophobia
|
common, 0.4% - 6.8%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Eye pain
|
common, 3.3% - 9.3%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Skin hyperpigmentation
|
common
|
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
|
Punctate keratitis
|
common
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
Vision blurred
|
postmarketing, common
|
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
Lacrimation
|
common
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
Sensation of foreign body
|
common, 2.1% - 9.9%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Visual disturbance
|
common, 4.6% - 7.7%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Eyelash darkening
|
common
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
Eye discharge
|
common, 0.8% - 4.1%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Erythema of eyelid
|
common, 0.8% - 3.8%
|
|
x
|
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
Eye irritation
|
common, 1.2% - 3.5%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Eyelash discolouration
|
0.4% - 5.2%
|
|
|
|
|
|
|
|
|
|
|
x
|
Asthenopia
|
common, 0.4% - 3.1%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Blepharitis
|
common, 1.7% - 2.9%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Lacrimation increased
|
postmarketing — 1.5% - 2.7%
|
|
x
|
x
|
|
|
|
|
x
|
x
|
|
x
|
Keratitis
|
2.3% - 2.5%
|
|
|
|
|
|
|
|
|
|
|
x
|
Eyelids pruritus
|
postmarketing — 0.2% - 4.1%
|
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
Conjunctival oedema
|
common, 1.2% - 1.9%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Stinging
|
0.8% - 2.1%
|
|
|
|
|
|
|
|
|
|
|
x
|
Conjunctivitis allergic
|
common, 0% - 1.5%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Asthenia
|
common, 0.8% - 1.4%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Cataract
|
1.2% - 2.9%
|
|
|
x
|
x
|
x
|
x
|
x
|
|
|
|
x
|
Corneal erosion
|
common, 0.8% - 1.2%
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Hypertension
|
postmarketing, 0.8% - 1.9%
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Blepharospasm
|
uncommon
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Common cold
|
uncommon
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
|
Infection
|
uncommon, 0.4% - 1.3%
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
x
|
Hirsutism
|
uncommon, 0% - 1.4%
|
|
|
|
x
|
x
|
|
|
x
|
x
|
x
|
x
|
Iritis
|
uncommon
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Retinal haemorrhage
|
uncommon
|
|
|
|
|
|
|
|
x
|
x
|
x
|
|
Upper respiratory tract infection
|
uncommon
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
|
Vertigo
|
uncommon
|
|
|
|
|
|
|
|
x
|
x
|
|
|
Eyelid retraction
|
uncommon
|
|
|
|
|
|
|
|
x
|
x
|
x
|
|
Dizziness
|
postmarketing, 0.5% - 1.2%
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Depression
|
0% - 1%
|
|
|
|
|
|
|
|
|
|
|
x
|
Rhinitis
|
0% - 1.9%
|
|
|
|
|
|
|
|
|
|
|
x
|
Eyelid oedema
|
postmarketing, uncommon
|
|
x
|
x
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Enophthalmos
|
postmarketing
|
|
|
|
|
|
|
|
x
|
x
|
x
|
|
Rash
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
x
|
Eye disorder
|
postmarketing
|
|
x
|
|
|
|
|
|
x
|
x
|
x
|
|
Gastrointestinal disorder
|
postmarketing
|
|
|
|
|
|
|
|
x
|
x
|
x
|
|
Nausea
|
postmarketing
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
|
Nervous system disorder
|
postmarketing
|
|
|
|
|
|
|
|
x
|
x
|
x
|
|
Erythema
|
postmarketing
|
|
|
|
|
|
|
|
x
|
x
|
|
|
Angiopathy
|
postmarketing
|
|
|
|
|
|
|
|
x
|
x
|
x
|
|
Burning sensation
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
|
Skin discolouration
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
|
Unspecified disorder of skin and subcutaneous tissue
|
postmarketing
|
|
x
|
|
|
|
|
|
x
|
x
|
x
|
|
Hair growth abnormal
|
postmarketing
|
|
x
|
x
|
|
|
x
|
x
|
x
|
x
|
|
|
Eye swelling
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
|
Macular oedema
|
postmarketing
|
|
|
|
|
|
|
|
x
|
x
|
|
|
Madarosis
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
x
|
|
Trichorrhexis
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
|
Iris hyperpigmentation
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
x
|
|
Eyelid irritation
|
postmarketing
|
|
x
|
x
|
|
|
|
|
|
|
|
|
Anxiety
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Arthritis
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Asthma
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Bronchitis
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Chalazion
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Chest pain
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Conjunctival disorder
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Conjunctival haemorrhage
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
Connective tissue disorder
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
Corneal oedema
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Cystitis
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Diplopia
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Dyspepsia
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Dyspnoea
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
Vitreous floaters
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Hordeolum
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Hypercholesterolaemia
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Hypertrichosis
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Inflammation
|
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
x
|
Cystoid macular oedema
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Mediastinal disorder
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
|
Nervousness
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Palpitations
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Pharyngitis
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Scotoma
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Sinusitis
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Uveitis
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Dry mouth
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Oedema peripheral
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Liver function test abnormal
|
|
|
|
|
x
|
x
|
x
|
x
|
|
|
x
|
x
|
Dry skin
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Urine abnormality
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Exacerbation of asthma
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Cough increased
|
|
|
|
|
|
|
|
|
|
|
|
x
|
COPD exacerbation
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Eye oedema
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Corneal calcification
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Erythema periorbital
|
|
|
x
|
x
|
|
|
|
x
|
|
|
x
|
|
Insomnia
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Conjunctival bleb
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Eyelid margin crusting
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Instillation site irritation
|
|
|
|
|
|
|
|
|
|
|
x
|
|
Eyelid pain
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Somnolence
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 25 |
Source: | Medsafe |
---|
Side effects: | 37 |
Source: | FDA Structured Product Label |
---|
Side effects: | 27 |
Source: | FDA |
---|
Side effects: | 27 |
Source: | FDA |
---|
Side effects: | 28 |
Source: | FDA Structured Product Label |
---|
Side effects: | 32 |
Source: | FDA Structured Product Label |
---|
Side effects: | 48 |
Source: | medicines.org.au |
---|
Side effects: | 48 |
Source: | Medsafe |
---|
Side effects: | 56 |
Source: | EMA |
---|
Side effects: | 67 |
Source: | Health Canada |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|